Association of IgG4‐Related Disease With History of Malignancy

Authors:

Abstract
Objective: IgG4‐related disease (IgG4‐RD) is a fibroinflammatory disease of unclear etiology. Some studies suggest that IgG4‐RD predisposes patients to malignancy or is a forme fruste of cancer, but we have frequently observed IgG4‐RD patients who have a history of malignancy preceding the clinical onset of IgG4‐RD. This study was undertaken to characterize IgG4‐RD in the setting of previous malignancy diagnosis.Methods: We identified IgG4‐RD patients with a history of invasive malignancy from a well‐defined cohort of 125 patients and compared their malignancy history to those of 2 reference groups. First, we calculated a standardized prevalence ratio against general US population estimates from the Surveillance, Epidemiology, and End Results (SEER) database. Second, we identified up to 5 age‐ and sex‐matched controls for each case and calculated the odds of malignancy among those with IgG4‐RD compared to controls, using conditional logistic regression.Results: The mean ± SD age at IgG4‐RD onset was 50.3 ± 14.9 years, and 61% of the patients were male. Twenty (16%) had been diagnosed as having malignancies (total 21 malignancies) before the diagnosis of IgG4‐RD. The observed prevalence of malignancy in this cohort was 2.5 times higher (95% confidence interval [95% CI] 1.1–3.6) than expected compared to the SEER database. Compared to matched controls, the frequency of history of malignancy was >3‐fold higher in IgG4‐RD patients (95% CI 1.6–6.2).Conclusion: Our findings suggest that, in a subset of patients with IgG4‐RD, malignancy may be associated with subsequent IgG4‐RD development. Potential explanations include shared risk factors for both IgG4‐RD and cancer, the triggering by cancer of autoantigen expression leading to IgG4‐RD, and an increased risk of IgG4‐RD resulting from cancer treatment.
Funding Information
  • National Institute of Allergy and Infectious Diseases (AI-110495)

This publication has 22 references indexed in Scilit: